GWM
GSK icon

Gilpin Wealth Management’s GSK GSK Stock Holding History

Gilpin Wealth Management’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$434 Sell
9
-50
-85% -$2.55K ﹤0.01% 889
2026
Q2 		$3.09K Hold
59
– – ﹤0.01% 404
2026
Q1 		$3.26K Hold
59
– – ﹤0.01% 386
2025
Q4 		$2.89K Buy
+59
New +$2.75K ﹤0.01% 374

Other funds holding GSK

DLA
Douglas Lane & Associates New York $7.46B AUM 24.36% 1-Year Est. Return
SIS
Sound Income Strategies Ft Lauderdale, Florida $2.24B AUM 8.38% 1-Year Est. Return
KFP
Keystone Financial Planning Cleveland, Ohio $404M AUM 16.77% 1-Year Est. Return
BE
Bonness Enterprises Washington, District of Columbia $307M AUM 22.88% 1-Year Est. Return
FFA
Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return
PC
Parrish Capital Kennesaw, Georgia $103M AUM 35.11% 1-Year Est. Return
IRC
Investors Research Corp Atlanta, Georgia $569M AUM 15.41% 1-Year Est. Return
BCM
Boltwood Capital Management Walnut Creek, California $443M AUM 17.72% 1-Year Est. Return
VCM
Versant Capital Management Phoenix, Arizona $1.17B AUM 28.44% 1-Year Est. Return
CPBTD
Central Pacific Bank - Trust Division Honolulu, Hawaii $952M AUM 25.15% 1-Year Est. Return

Gilpin Wealth Management's GSK Position: Q3 2026 in Review

Gilpin Wealth Management reduced its GSK (GSK) stake by 85% in Q3 2026, selling an estimated $2.55K and leaving 9 shares worth $434. The position accounts for ﹤0.01% of the portfolio, ranked #889.

Gilpin Wealth Management first reported a position in GSK in Q4 2025 and has held it in 4 quarters since. The position peaked at $3.26K in Q1 2026. 44 funds tracked by Wall St. Rank hold GSK as of Q3 2026.

  • Gilpin Wealth Management held 9 shares of GSK worth $434 as of Q3 2026.
  • Gilpin Wealth Management sold 50 GSK shares in Q3 2026, an estimated $2.55K.
  • GSK made up ﹤0.01% of Gilpin Wealth Management's portfolio in Q3 2026, its #889 holding.
  • Gilpin Wealth Management first reported a position in GSK in Q4 2025 and has held it in 4 quarters since.
  • Gilpin Wealth Management's GSK position peaked at $3.26K in Q1 2026.
  • 44 funds tracked by Wall St. Rank held GSK as of Q3 2026.

Based on Gilpin Wealth Management's 13F filing for Q3 2026, filed 9 Oct 2026.